Pergamum acquires remaining stake in Lipopeptide - MarketLine Financial Deals

Pergamum acquires remaining stake in Lipopeptide

Pergamum acquires remaining stake in Lipopeptide - MarketLine Financial Deals
Pergamum acquires remaining stake in Lipopeptide
Published Dec 31, 2010
2 pages — Published Dec 31, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pergamum AB, a clinical-stage biopharmaceutical company focused on developing peptide-based products in dermatology, wound healing and anti-infection, has acquired the remaining stake in Lipopeptide AB.

  
Source:
Document ID
MA53656_110310
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pergamum acquires remaining stake in Lipopeptide" Dec 31, 2010. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pergamum-acquires-remaining-stake-in-Lipopeptide-2052-57263>
  
APA:
MarketLine Financial Deals. (2010). Pergamum acquires remaining stake in Lipopeptide Dec 31, 2010. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pergamum-acquires-remaining-stake-in-Lipopeptide-2052-57263>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.